It's time for Indian generic companies to rethink their strategies, says Bhupesh Bhandari. In July, the European Commission imposed fines of euro 427.7 million on Servier of France and five......
The European Commission on Wednesday imposed a fine of Euro146 million on nine pharma companies, including Ranbaxy Laboratories, for delaying market entry of cheaper generic versions of......
Frequent drug recalls from the US in the recent past by Indian companies have raised concern among industry experts as well as the investor fraternity.Some of the major pharmaceutical companies......
Patent settlements between pharmaceutical companies that make original drugs and their generic manufacturing rivals are to come under renewed scrutiny from the European Union's competition......
Close on the heels of allegations that India's weak patent laws deter big pharmaceutical companies of the West from investing in India, a study by a Swedish University has accused India's Active......